Recent pharmaceutical innovations have introduced a new avenue for weight loss: drugs based on gut hormones such as GLP-1 and ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

Tiny doses of the weight-loss drug can sidestep its unpleasant side effects, say influencers. But is customising the dose a ...

We have had to make this difficult decision in order to protect other vital NHS services and also to test ways of delivering this new generation of weight loss medications." The jab should be ...

In the quest for effective weight loss solutions, many individuals find themselves overwhelmed by the many products available ...

Find out how age and weight go together, here. Plus, expert tips for losing weight after 50, including diet plans, calorie ...

Tirzepatide, the main ingredient in Mounjaro and Zepbound, is no longer in shortage, according to the U.S. Food and Drug ...

People who use Ozempic or Wegovy for weight loss often find ... are smaller on these medications, we want to optimize nutritional intake and consume the ‘best’ calories available,” he ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...